Medindia

X

The Global Dermatology Market to 2026

Wednesday, November 16, 2016 Drug News J E 4
Advertisement

NEW YORK, Nov. 16, 2016 /PRNewswire/ -- GMR Data forecasts that revenues for the dermatology drug market will reach $83.2bn in 2026. In this brand new, independently created, pharmaceutical report discover prospects for leading companies and products in the dermatology drugs market today. 5 Reasons why you must read this report today:

1. Dermatology drug manufacturers are enjoying higher revenues than ever before in this niche market and with increasing prevalence of skin diseases, this will continue across the next decade. 

2. A number of leading drugs are set to come off of patent across the forecast period.

3. Pipeline products addressing areas of unmet clinical need, especially in the acne, skin infections and skin cancer markets with the potential to become blockbusters, will launch during the forecast period.

4. Understanding the areas of the market in which growth will occur allows for a more tailored approach to expansion, increasing the chances of success.

5. GMR Data's report gives an in depth and independent view of the leading companies in the dermatology drugs market, ensuring you have all the information needed when moving forward. 

Included in the report is analysis of the leading companies and geographies in the dermatology drugs market, as well as of the opportunities and threats facing manufacturers. The report has forecasts for all key submarkets in the market as well as for the leading drugs. The primary companies in the market are studied with pipeline products and merger & acquisitions in relation to the dermatology sector. 

In the report, you will find revenue forecasts to 2026 for the following submarkets in the dermatology drugs market:

AcnePsoriasisAlopeciaSkin CancerSkin InfectionsAtopic Dermatitis 

The report provides profiles and key existing / pipeline dermatology drugs for the following key companies operating within the dermatology drugs market:

AllerganGaldermaValeant pharmaceuticalsNovartisMerckPierre Fabre 

This independent, 152 page report guarantees you will remain better informed than your competition. With over 150 tables and figures examining the dermatology drugs market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leaders market revenue forecasts as well as analysis to 2026, which keeps your knowledge that one step ahead, helping you to succeed.

This report is essential reading for you or anyone in the pharmaceutical or health care sectors. Purchasing this report today will help you to recognise those important market opportunities and understand the possibilities there.

Read the full report: http://www.reportlinker.com/p04336530-summary/view-report.html

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________

Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-global-dermatology-market-to-2026-300364016.html

SOURCE Reportlinker

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Germany Healthcare IT Market Outlook to 2022 - Cli...
S
The mHealth (Mobile Healthcare) Ecosystem: 2017 - ...